Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

January 11, 2024

https://www.globenewswire.com/news-release/2024/01/11/2807853/0/en/Spectral-AI-Begins-Enrollment-in-Pivotal-Study-to-Validate-DeepView-AI-for-Burn-Injuries.html

DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in clinical wound care, announces the enrollment of the first patient in the pivotal study to validate DeepView AI® using its proprietary imaging technology for burn size and healing assessment. This pivotal study is expected to be the final clinical trial before seeking FDA marketing authorization for the burn indication in 2025 and will be conducted in burn centers and emergency departments across the US, enrolling both adults and pediatric patients.

Read more at globenewswire.com

Related news for (MDAI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.